Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Encapsulated Benzoyl Peroxide

Small molecule · developed by Sol-Gel Technologies

Phase 1 Most advanced trial (none active)
SLGL Developer
1 Registered trials

What is Encapsulated Benzoyl Peroxide?

Encapsulated Benzoyl Peroxide is a topical cream formulation of benzoyl peroxide, applied to the face. It is studied in papulopustular rosacea.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Small molecule
Therapy area
Dermatology
Developer
Sol-Gel Technologies, Ltd. (SLGL)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05675501 Phase 1 Papulopustular Rosacea Completed SLGL

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Papulopustular Rosacea

More from Sol-Gel Technologies

Sources

Updated Nov 1, 2026. Something wrong or missing? Report it on the SLGL page.

Follow SLGL, the company behind Encapsulated Benzoyl Peroxide

See SLGL's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

SLGL catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.